"I always tell the truth, even when I lie." Today we are joined by our CRISPR Goddess and cover the Fulcrum Therapeutics REACH phase 3 clinical trial data release and discuss our journey with Fulcrum from the beginning. While very disappointing from several aspects, in the end a lot of benefit truly has been gained for the FSHD field and we are grateful for Fulcrum's contributions to help others going forward. And there are many others coming along, this is the beginning and not the end for FSHD therapeutics.
Podden och tillhörande omslagsbild på den här sidan tillhör Peter L Jones, PhD. Innehållet i podden är skapat av Peter L Jones, PhD och inte av, eller tillsammans med, Poddtoppen.
